This information was published on 2025-06-06T12:08:03 for IP Right Filed Published.
| Field | Value |
| (210) | 2554488 |
| (220) |
06 Jun 2025
|
| (511) (510) |
Class 40
Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies to the order and specification of others. Class 42 Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; product research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies. |
| (540) |
|
| (550) | Figurative |
| (730) |
SCT Cell Manufacturing s.r.o.
|
| (750) |
Minter Ellison
|
Find out more about publications on the About page.